Why the study?
Does programmed ventricular stimulation predict prognosis or guide effective therapy in patients with left ventricular dysfunction and ventricular tachycardia?
Does programmed ventricular stimulation predict prognosis or guide effective therapy in patients with left ventricular dysfunction and ventricular tachycardia?
In patients with LV dysfunction and VT, inducibility during programmed ventricular stimulation does not predict an unfavorable course, though electrophysiologically guided effective drug therapy is associated with a good prognosis.
Inducibility does not predict prognosis in LV dysfunction with VT; leaves open its role in guiding therapy from observational data.
We performed programmed ventricular stimulation on 69 patients with left ventricular ejection dysfunction (ejection fraction < 50%) and clinically recognized ventricular tachycardia including 28 patients with sustained ventricular tachycardia and 41 patients with nonsustained ventricular tachycardia. An inducible arrhythmia (> 6 beats ventricular tachycardia) was found in 74% of patients. Patients with clinically sustained arrhythmias were frequently inducible (89%) with a high incidence of inducible monomorphic ventricular tachycardia (82%). Patients with clinically nonsustained ventricular tachycardia had a lower rate of inducibility (63%) including a high incidence of inducible polymorphic ventricular tachycardia (27%). Inducible patients with left ventricular dysfunction and ventricular tachycardia had a low incidence of electrophysiologically demonstrated effective drug therapy (16%). However, if an effective drug was found, the prognosis was good. Empirical drug therapy was associated with a poor prognosis in inducible and noninducible patients. Finally, an unfavorable prognosis was associated with a clinically sustained arrhythmia, a lower ejection fraction, and the presence of a left ventricular aneurysm. An inducible arrhythmia did not predict an unfavorable course. Indeed, patients with noninducible ventricular tachycardia in this group of patients were still at risk for sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Flaker et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: